Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Sang-Yi Moon"'
Publikováno v:
Diagnostics, Vol 14, Iss 22, p 2517 (2024)
Background and Aims: Multiple non-invasive tests (NITs) for identifying advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD) are available, but, due to the limitations of single NITs, the American Association for the Study of
Externí odkaz:
https://doaj.org/article/76eedf1b2a004b9d9d6e48b13b0510f0
Publikováno v:
Virology Journal, Vol 21, Iss 1, Pp 1-10 (2024)
Abstract Background Conflicting evidence exists regarding the effects of ursodeoxycholic acid (UDCA) on coronavirus disease 2019 (COVID-19). This study investigates the association between UDCA administration and COVID-19 infection and its related ou
Externí odkaz:
https://doaj.org/article/121b3ab4138847058d5f139fda3f71e9
Autor:
Sang Yi Moon, Yang Hyun Baek, Se Young Jang, Dae Won Jun, Ki Tae Yoon, Young Youn Cho, Hoon Gil Jo, Ae Jeong Jo
Publikováno v:
Gut and Liver, Vol 18, Iss 2, Pp 283-293 (2024)
Background/Aims: Noninvasive methods have become increasingly critical in the diagnosis of fibrosis in chronic liver diseases. Herein, we compared the diagnostic performance of serum Mac2 binding protein glycosylation isomer (M2BPGi) and other serolo
Externí odkaz:
https://doaj.org/article/49380aa8141e4b47b20082d9f8e87ef7
Autor:
Hye Ryeon Kim, Minkook Son, Seok Jae Huh, Sang Yi Moon, Hyeyeon Moon, Yeo Wool Kang, Myeongseok Koh, Jong Yoon Lee
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundSeveral previous studies found a positive relationship between metabolic syndrome (MetS) and thyroid cancer (TC) risk. However, there is no research that has studied the relationship between the metabolic score for insulin resistance (METS-
Externí odkaz:
https://doaj.org/article/62f69baef1044ee292ca74a27658282b
Publikováno v:
The Korean Journal of Gastroenterology, Vol 82, Iss 1, Pp 35-39 (2023)
The results of the IMbrave150 study have led to widespread use of the combination therapy of atezolizumab and bevacizumab as a first-line treatment for unresectable or metastatic hepatocellular carcinoma (HCC). Compared to traditional cytotoxic chemo
Externí odkaz:
https://doaj.org/article/6582483b7be6436a948eab864f64b137
Autor:
Yeo Wool Kang, Yang Hyun Baek, Jong Hoon Lee, Young Hoon Roh, Hee Jin Kwon, Sang Yi Moon, Min Kook Son, Jin Sook Jeong
Publikováno v:
Diagnostics, Vol 14, Iss 11, p 1083 (2024)
Background: Non-alcoholic fatty liver disease (NAFLD) encompasses a heterogeneous spectrum ranging from simple steatosis to fibrosis and cirrhosis. Fibrosis, associated with long-term overall mortality and liver-related events, requires evaluation. T
Externí odkaz:
https://doaj.org/article/5f41da44f2524512a827e7205eab9f9e
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
IntroductionAlthough most patients with alcohol-related liver disease (ALD) have a history of prolonged and heavy drinking, there is no clear threshold defining the level of alcohol consumption that leads to ALD. We aimed to evaluate the correlation
Externí odkaz:
https://doaj.org/article/9809b867c48e40ddbad1c1aa45a1fdc0
Publikováno v:
Journal of Liver Cancer, Vol 22, Iss 1, Pp 57-62 (2022)
Currently, various tyrosine kinase inhibitors and immune checkpoint inhibitors have been suggested in the treatment guidelines for advanced hepatocellular carcinoma (HCC). However, sorafenib was the only systemic drug approved 10 years ago. In 2010,
Externí odkaz:
https://doaj.org/article/4cfe1853cc6848de9fef992f0a240412
Publikováno v:
Kosin Medical Journal, Vol 36, Iss 2, Pp 161-168 (2021)
Transarterial chemoembolization is often the first-line treatment for multiple hepatocellular carcinomas. However, hepatic arterial infusion chemotherapy is a treatment option for hepatocellular carcinoma refractory to multiple sessions of transarter
Externí odkaz:
https://doaj.org/article/a960c71c2bdc44919c11b438e746b69f
Publikováno v:
The Korean Journal of Gastroenterology, Vol 73, Iss 6, Pp 360-364 (2019)
Albendazole is used as a typical antiparasitic agent worldwide. The side effects of albendazole may include nausea, vomiting, abdominal pain, dizziness, headache, alopecia, and increased liver enzymes. Mild elevation of the liver enzyme has been repo
Externí odkaz:
https://doaj.org/article/f71a21e20bf3493f90eb63b40d75abbe